2002年世界卫生组织西太平洋区域淋病奈瑟菌抗生素耐药性监测

Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002.

出版信息

Commun Dis Intell Q Rep. 2003;27(4):488-91. doi: 10.33321/cdi.2003.27.77.

DOI:10.33321/cdi.2003.27.77

Abstract

The World Health Organization's Western Pacific Region (WHO WPR) long standing programme for surveillance of antimicrobial resistance in Neisseria gonorrhoeae, GASP, continued in 2002. Seventeen countries contributed data on about 11,500 gonococci by determining susceptibility patterns using standardised methodologies. Resistance to quinolone and penicillin antibiotics remained widely dispersed and at historically high levels. Gonococci with decreased susceptibility to third generation cephalosporins were again observed in several centres. Spectinomycin resistance was infrequently encountered. Control of gonorrhoea in the WHO WPR is compromised by the further reduction in options for cheap and effective treatment of gonorrhoea.

摘要

世界卫生组织西太平洋区域（WHO西太区）长期开展的淋病奈瑟菌耐药性监测项目（GASP）于2002年继续进行。17个国家通过使用标准化方法确定药敏模式，提供了约11500株淋球菌的数据。对喹诺酮类和青霉素类抗生素的耐药性仍然广泛存在，且处于历史高位。在几个中心再次观察到对第三代头孢菌素敏感性降低的淋球菌。很少遇到对壮观霉素耐药的情况。淋病治疗的廉价有效选择进一步减少，这对WHO西太区淋病的控制造成了不利影响。